Log in to save to my catalogue

NAFLD in type 1 diabetes: overrated or underappreciated?

NAFLD in type 1 diabetes: overrated or underappreciated?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_309a074d7b7f4f34b4d8166ab91feff0

NAFLD in type 1 diabetes: overrated or underappreciated?

About this item

Full title

NAFLD in type 1 diabetes: overrated or underappreciated?

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in endocrinology and metabolism, 2021-11, Vol.12, p.20420188211055557-20420188211055557

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries, affecting 25–30% of the general population and up to 65% in those with obesity and/or type 2 diabetes. Accumulation of visceral adipose tissue and insulin resistance (IR) contributes to NAFLD. NAFLD is not an innocent entity as it not only may ca...

Alternative Titles

Full title

NAFLD in type 1 diabetes: overrated or underappreciated?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_309a074d7b7f4f34b4d8166ab91feff0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_309a074d7b7f4f34b4d8166ab91feff0

Other Identifiers

ISSN

2042-0188

E-ISSN

2042-0196

DOI

10.1177/20420188211055557

How to access this item